Authors' response

Andrea Zanichelli¹, Walter A Wuillemin², Aleena Banerji³, Paula J Busse⁴, Stephen D Betschel⁵, Mauro Cancian⁶, Remi Gagnon⁷, M Dawn Goodyear⁸, Tamar Kinaciyan⁹, Aharon Kessel¹⁰, Markus Magerl¹¹, Andreas Recke¹², H James Wedner¹³, Daniel Nova Estepan¹⁴, Maureen Watt¹⁵, Irmgard Andresen¹⁶, Salomé Juethner¹⁷, Natalie Khutoryansky¹⁵, Inmaculada Martinez-Saguer¹⁸

Affiliations

¹ Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy; Dipartimento di Scienze Biomediche per la Salute, University of Milan, Milan, Italy.
² Division of Hematology and Hematology Laboratory, Department of Internal Medicine, Luzerner Kantonsspital, Lucerne and University of Berne, Berne, Switzerland.
³ Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁵ Division of Clinical Immunology and Allergy, University of Toronto, Toronto, Ontario, Canada.
⁶ Department of Systems Medicine, University Hospital of Padua, Padua, Italy.
⁷ Laval University, Centre Hospitalier Universitaire de Québec, Québec, Quebec, Canada.
⁸ Division of Hematology and Hematologic Malignancies, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁹ Department of Dermatology, Medical University of Vienna, Vienna, Austria.
¹⁰ Division of Allergy and Clinical Immunology, Bnai Zion Medical Centre, Technion Faculty of Medicine, Haifa, Israel.
¹¹ Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Immunology and Allergology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
¹² Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany.
¹³ Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
¹⁴ Takeda Development Center Americas, Inc, Lexington, Massachusetts. Electronic address: Daniel.novaestepan@takeda.com.
¹⁵ Takeda Development Center Americas, Inc, Lexington, Massachusetts.
¹⁶ Takeda Pharmaceuticals International AG, Zurich, Switzerland.
¹⁷ Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts.
¹⁸ HZRM Hemophilia Center Rhine Main, Frankfurt/Main, Germany.

PMID: 41419271
DOI: 10.1016/j.anai.2025.09.024

Authors' response

Andrea Zanichelli et al. Ann Allergy Asthma Immunol. 2026 Jan.

. 2026 Jan;136(1):113-115.

doi: 10.1016/j.anai.2025.09.024.

Authors

Affiliations

¹ Operative Unit of Medicine, Angioedema Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy; Dipartimento di Scienze Biomediche per la Salute, University of Milan, Milan, Italy.
² Division of Hematology and Hematology Laboratory, Department of Internal Medicine, Luzerner Kantonsspital, Lucerne and University of Berne, Berne, Switzerland.
³ Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, New York.
⁵ Division of Clinical Immunology and Allergy, University of Toronto, Toronto, Ontario, Canada.
⁶ Department of Systems Medicine, University Hospital of Padua, Padua, Italy.
⁷ Laval University, Centre Hospitalier Universitaire de Québec, Québec, Quebec, Canada.
⁸ Division of Hematology and Hematologic Malignancies, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁹ Department of Dermatology, Medical University of Vienna, Vienna, Austria.
¹⁰ Division of Allergy and Clinical Immunology, Bnai Zion Medical Centre, Technion Faculty of Medicine, Haifa, Israel.
¹¹ Institute of Allergology, Charité-Universitätsmedizin Berlin (corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany; Immunology and Allergology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
¹² Department of Dermatology, Allergology and Venereology, University of Lübeck, Lübeck, Germany.
¹³ Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
¹⁴ Takeda Development Center Americas, Inc, Lexington, Massachusetts. Electronic address: Daniel.novaestepan@takeda.com.
¹⁵ Takeda Development Center Americas, Inc, Lexington, Massachusetts.
¹⁶ Takeda Pharmaceuticals International AG, Zurich, Switzerland.
¹⁷ Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts.
¹⁸ HZRM Hemophilia Center Rhine Main, Frankfurt/Main, Germany.

PMID: 41419271
DOI: 10.1016/j.anai.2025.09.024

No abstract available

PubMed Disclaimer

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Authors' response

Affiliations

Authors' response

Authors

Affiliations

Publication types

LinkOut - more resources

Full Text Sources